K123802

Substantially Equivalent

EASYRA TBIL REAGENT, EASYRA DBII REAGENT, EASYRA CK REAGENT

Applicant: Medica Corp.
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 2012-12-10
Decision date: 2013-03-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.